Takeda Pharmaceutical Co Ltd
Pharmaceuticals
Company Summary
Takeda Pharmaceutical Co., Ltd. is a leading pharmaceutical company based in Japan with a focus on oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies. With a strong presence in the US, Japan, Europe and Canada, the company generates revenue of JPY 4.3 trillion. Takeda Pharmaceutical has a medium risk ESG score of 21.6.
ESG Rating Overview
Sustainalytics
Overall ESG Rating :
24.3
Rating Scale
0-10Negligible10-20Low20-30Med30-40High40+Severe
Ranking
Industry Group
Pharmaceuticals127 out of 921
Universe
Global Universe5897 out of 16215
LSEG
Overall ESG Rating :
83
Rating Scale
0-25Poor 25-50Satisfactory 50-75Good75-100Excellent
MSCI
Overall ESG Rating :
A
Rating Scale
CCCB
Laggard
BBBBBA
Average
AAAAA
Leader
Takeda is average among 80 companies in the pharmaceuticals industry.
Temperature Rise :
1.3℃
CLIMATE SCALE
≥ 3.85°CLagging > 2°C - < 3.85°CMisaligned ≤ 2°CAligned
